Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
Board directors appointed at Athersys, Trillium Therapeutics and Viatris
Marinus Pharmaceuticals secures a new chief commercial officer, PledPharma names a new vice-president of commercial operations.
Board directors appointed at AstraZeneca and Miragen Therapeutics, redesignated at Shanghai Fosun Pharma
New Chief Technology Officers named at Seres Therapeutics, ERYTech Pharma and Adicet Bio
Diffusion Pharmaceuticals and WPD Pharmaceuticals get new chief medical officers.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.
A new CEO is appointed at AZTherapies, while directors are named at AstraZeneca, Pfenex, X4 Pharmaceuticals and Medicenna Therapeutics.
American Injectables gets a new CEO, while Hemostemix names a new chief medical officer.
The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.
New directors at 4D Pharma, Neurogene And Zogenix.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.